Cargando…
Genetic alterations and their therapeutic implications in epithelial ovarian cancer
BACKGROUND: Genetic alterations for epithelial ovarian cancer are insufficiently characterized. Previous studies are limited regarding included histologies, gene numbers, copy number variant (CNV) detection, and interpretation of pathway alteration patterns of individual patients. METHODS: We sequen...
Autores principales: | Lapke, Nina, Chen, Chien-Hung, Chang, Ting-Chang, Chao, Angel, Lu, Yen-Jung, Lai, Chyong-Huey, Tan, Kien Thiam, Chen, Hua-Chien, Lu, Hsiao-Yun, Chen, Shu-Jen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097933/ https://www.ncbi.nlm.nih.gov/pubmed/33947352 http://dx.doi.org/10.1186/s12885-021-08233-5 |
Ejemplares similares
-
Prevalence and clinical significance of BRCA1/2 germline and somatic mutations in Taiwanese patients with ovarian cancer
por: Chao, Angel, et al.
Publicado: (2016) -
Mutations in circulating tumor DNA detected in the postoperative period predict poor survival in patients with ovarian cancer
por: Chao, Angel, et al.
Publicado: (2023) -
TP53 DNA Binding Domain Mutations Predict Progression-Free Survival of Bevacizumab Therapy in Metastatic Colorectal Cancer
por: Hsu, Hung-Chih, et al.
Publicado: (2019) -
Advanced Lung Adenocarcinoma Patient with ERBB2 Amplification Identified by Comprehensive Genomic Profiling Benefits from Trastuzumab
por: Tao, Chi-Wei, et al.
Publicado: (2020) -
Liquid Biopsy Detects Relapse Five Months Earlier than Regular Clinical Follow-Up and Guides Targeted Treatment in Breast Cancer
por: Cheng, Fiona Tsui-Fen, et al.
Publicado: (2019)